2024
Food Insecurity and Hypoglycemia among Older Patients with Type 2 Diabetes Treated with Insulin or Sulfonylureas: The Diabetes & Aging Study
Karter A, Parker M, Huang E, Seligman H, Moffet H, Ralston J, Liu J, Gilliam L, Laiteerapong N, Grant R, Lipska K. Food Insecurity and Hypoglycemia among Older Patients with Type 2 Diabetes Treated with Insulin or Sulfonylureas: The Diabetes & Aging Study. Journal Of General Internal Medicine 2024, 39: 2400-2406. PMID: 38767746, PMCID: PMC11436613, DOI: 10.1007/s11606-024-08801-y.Peer-Reviewed Original ResearchType 2 diabetes treated with insulinOlder patientsSevere hypoglycemiaFood insecurityAssociated with severe hypoglycemiaCharlson comorbidity scoreFood insecurity questionsCross-sectional studyComorbidity scoreSelf-reported reasonsMissed mealsHigh riskRisk factorsPatientsHypoglycemiaResultsFood insecurityFinancial strainDiabetesPrevention effortsAging StudySulfonylureaMedicationInsulinAgeRisk
2021
Obesity Is Associated With Intensive Care Use and Duration of ICU Stay but Not Mortality Among 3246 Patients Hospitalized With COVID-19
Kang Y, Brancale J, Athonvarangkul D, Alausa J, Subair L, Lipska K, Jastreboff A. Obesity Is Associated With Intensive Care Use and Duration of ICU Stay but Not Mortality Among 3246 Patients Hospitalized With COVID-19. Journal Of The Endocrine Society 2021, 5: a61-a62. PMCID: PMC8089233, DOI: 10.1210/jendso/bvab048.125.Peer-Reviewed Original ResearchIntensive care useAssociation of obesityICU careBody mass indexCare useHigh riskAcute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionPositive RT-PCR assaySyndrome coronavirus 2 infectionMultivariate logistic regression analysisCOVID-19Association of underweightCoronavirus 2 infectionDuration of ICUHypoxic respiratory failureNoninvasive ventilatory supportSevere coronavirus diseaseNormal-weight adultsLonger durationLogistic regression analysisSARS-CoV-2Health care systemRT-PCR assaysICU stay
2020
379-P: Glucagon Use by U.S. Adults with Type 1 and Type 2 Diabetes
KAHN P, LIU S, MCCOY R, GABBAY R, LIPSKA K. 379-P: Glucagon Use by U.S. Adults with Type 1 and Type 2 Diabetes. Diabetes 2020, 69 DOI: 10.2337/db20-379-p.Peer-Reviewed Original ResearchType 2 diabetesHigh-risk patientsType 1Diabetes patientsGlucagon useType 1 diabetes patientsAmerican Diabetes AssociationType 1 diabetesMedicare Advantage enrolleesPoor discriminative performanceGlucagon prescriptionsPrior hypoglycemiaRisk patientsDiabetes AssociationPrescribing practicesEndocrinology careMultivariable modelAdministrative claimsHigh riskPatientsType 2DiabetesModel AUCU.S. adultsGlucagon